Proceedings of the American Association for Cancer Research

publication venue for

Attempts to increase blood flow in the rat solid Walker 256 tumor by the use of the perfluorochemical emulsion fluosol-DA (F-DA). VOL. 26. 1985
Complete tumor ablation with iodine 131 radiolabeled monoclonal antibody (Mab) against human neuroblastoma (NB) xenografted in nude mice. VOL. 26. 1985
Enhancement of differentiation of HL-60 cells by pulsatile electromagnetically induced currents (PEMIC). VOL. 26. 1985
Hematopoietic function in germ cell tumor (GCT) patients (Pts) in complete remission (CR) after cisplatin (DDP)-based chemotherapy (CRx). VOL. 26. 1985
Human neuroblastoma (NB) xenografts: A model for optimizing tumor targeting of GD2 specific monoclonal antibody (Mab) in vivo. VOL. 26. 1985
Immunolymphoscintigraphy of pulmonary and mediastinal lymph nodes: A new approach to lung cancer imaging. VOL. 26. 1985
Isolation of hamster cell lines containing a human DNA repair gene. VOL. 26. 1985
Pharmacokinetics of free platinum (FP) and total platinum (TP) after administration of cisplatin (DDP) in hypertonic saline (HS). VOL. 26. 1985
Pharmacokinetics of intravesical methotrexate (MTX) for superficial bladder tumors. VOL. 26. 1985
Phase I study of oral idarubicin (4DMDR) in children with cancer. VOL. 26. 1985
Phase I trial and clinical pharmacologic study of 10-ethyl-10-deaza-aminopterin (10-EdAM). VOL. 26. 1985
Phase I trial of taxol given as a three hour infusion every three weeks. VOL. 26. 1985
Phase I-II trial of fludarabine phosphate in acute leukemia. VOL. 26. 1985
Phase II trial of N-methyl formamide (NMF) in patients with advanced colorectal carcinoma. VOL. 26. 1985
The in vitro effect of high energy shock waves on human prostate cancer cell line PC-3. VOL. 26. 1985
VP-16 inhibits calla antibody-induced modulation of a lymphoblastic cell line. VOL. 26. 1985
Verapamil enhances cytotoxicity of vincristine (VCR) and 5 fluorouracil (5FU) in-vitro and in-vivo. VOL. 26. 1985
4'(9-acridinylamino) methanesulfon-anisidide (AMSA)-cyclocytidine (cyclo) in children with acute leukemia. Vol. 23. 1982
Effect of low-dose adriamycin-containing combination chemotherapy (MOPP/ABVD) and low-dose mediastinal radiotherapy (RT) on cardiac function in untreated advanced Hodgkin's disease (HD). Vol. 23. 1982
Phase I trial of 4-demethoxydaunorubicin (4-DM). Vol. 23. 1982
Phase II chemotherapy of pancreatic adenocarcinoma with m-AMSA (4'-9-acridinylamino)-methanesulfon-M-anisidide). Vol. 23. 1982
Phase II trial of 9,10-anthracene dicarboxyaldehyde bis[4,5-dihydro-1H-imidazol-2-yl) hydrazone] dihydrochloride (CL 216,942) in colon carcinoma. Vol. 23. 1982
Regional methotrexate entry into experimental rat brain tumors as measured by quantitative autoradiography (QAR). Vol. 23. 1982
Streptozotocin and adriamycin in the treatment of APUD tumors (carcinoid, islet cell and medullary carcinomas of the thyroid). Vol. 23. 1982
The treatment of extragonadal seminoma. Vol. 23. 1982
A randomized trial of semustine (M), vincristine (O), 5-fluorouracil (F), [MOF] + streptozotocin (S) [MOF-S] in advanced colorectal cancer. Vol. 22. 1981
Acridinylamino anisidide (AMSA) in children with leukemia and lymphoma. Vol. 22. 1981
Cisplatin, vindesine, and bleomycin combination chemotherapy of esophageal cancer. Vol. 22. 1981
Effect of total parenteral nutrition (TPN) on metabolic parameters of patients undergoing ablative chemotherapy. Vol. 22. 1981
Improved remission rate and duration in nodular non-Hodgkin lymphoma (NNHL) with the use of mixed bacterial vaccine (MBV). Vol. 22. 1981
Initial clinical evaluation of FIAC, a drug with potent anti-herpes virus activity. Vol. 22. 1981
Non-monotonic dose-response to chemotherapy of murine B-16 melanoma (MM). Vol. 22. 1981
Pharmacodynamics, drug concentration and histology of osteosarcoma following treatment with intra-arterial cisplatinum (IACDP). Vol. 22. 1981
Phase II trial of vindesine in malignant mesothelioma. Vol. 22. 1981
Phase II trials of methylglyoxal bis (guanylhydrazone) (MGBG) in 3 solid tumors. Vol. 22. 1981
Synergistic effects of deoxycytidine (dCyd) on toxicity of thymidine (dThd) plus 5-fluorouracil (FUra) in HeLa cells. Vol. 22. 1981
VAB-6 with or without maintenance in resected nonseminomatous germ cell tumors (NSGCT) of the testis stage II-B. Vol. 22. 1981
VAB-6 without maintenance: Progress in chemotherapy of testicular germ cell tumors (GCT). Vol. 22. 1981
VP-16-213: A phase II study of non-small cell lung cancer (NSCLC). Vol. 22. 1981
Cell killing by ultra-low dose rate radiation: Population survival effects and interaction with conventional radiation and chemotherapeutic agents in Chinese hamster cells. Vol. 20. 1979
Cyclophosphamide (C) induced cardiac toxicity in children. Vol. 20. 1979
Difficulties in estimating the fraction of clonogenic cells in S phase using cloning efficiency in semi-solid medium in conjunction with cytotoxic hydroxyurea (HU) or 3H-thymidine (3H-TdR). Vol. 20. 1979
Improved leukocyte counts after chemotherapy with lithium carbonate. Vol. 20. 1979
Is maintenance therapy necessary following complete remission of stage III testis cancer?. Vol. 20. 1979
Phase I trial of AMSA (4'-(9-acrindylamino)-methanesulfon-m-anisidide). Vol. 20. 1979
Salvage of heavily pretreated Hodgkin's disease patients with intensive combination chemotherapy. Vol. 20. 1979
Spirohydantoin mustard (NSC-172112) penetration of brain and systemic organs. Vol. 20. 1979
Treatment of advanced breast cancer with a novel cyclophosphamide (C), methotrexate (M), 5-fluorouracil (F), vincristine (V) and prednisone (P) regimen. Vol. 20. 1979
Trial of rubidazone in children with cancer. Vol. 20. 1979
Vindesine (DVA) in the treatment of patients with metastatic colorectal carcinoma. Vol. 20. 1979
Vindesine in the treatment of esophageal carcinoma. Vol. 20. 1979
A new method for screening anti-cancer agents on solid tumors. Vol. 19. 1978
Chemotherapy of ovarian carcinoma: randomization between melphalan and adriamycin-cyclophosphamide. Vol. 19. 1978
Cis-diammine dichloroplatinum (II) (DDP) and bleomycin in the treatment of esophageal carcinoma. Vol. 19. 1978
Comparison of adriamycin (ADRIA) and 5-fluorouracil (5 FU) in advanced prostatic cancer. Vol. 19. 1978
Long term remission of acute non-lymphocytic leukemia in patients with previously treated testicular carcinoma. Vol. 19. 1978
Methyl CCNU (MeCCNU), 5-fluorouracil (5-FU), vincristine and streptozotocin (MOF-STREP) for metastatic colorectal carcinoma. Vol. 19. 1978
Pharmacokinetics of gallium nitrate. Vol. 19. 1978
Phase I evaluation of thymidine plus fluorouracil (TdR+FU) in patients with advanced cancer. Vol. 19. 1978
Phase I study of chlorozotocin. Vol. 19. 1978
Results at three years of 8-drug combination chemotherapy and local radiotherapy for advanced Hodgkin's disease. Vol. 19. 1978
2,2' anhydro-1-B-D-arabinofuranosyl 5-fluorocytosine (AAFC) in the treatment of metastatic gastrointestinal cancers. VOL.18. 1977
Combination chemotherapy (M 2 protocol) of Waldenstrom's macroglobulinemia with melphalan, cyclophosphamide, vincristine, and BCNU (1,3 bis(2 chlorethyl) 1 nitrosourea, (M 2 protocol). Vol.18. 1977
High dose C. parvum administration by continuous infusion. Vol.18. 1977
Randomization study of 2 different schedules of methyl CCNU (MeCCNU), 5 flourouracil (5 FU), and vincristine (VCR) for metastatic colorectal carcinoma. Vol. 18. 1977
VAB III combination chemotherapy in childhood malignancies. Vol. 18. 1977
Vindesine (DVA) response in children with malignant diseases. Vol.18. 1977
Corynebacterium parvum immunopotentiation in cancer patients. Vol.17. 1976
DNA damage in the intracerebral (I.C.) rat gliosarcoma 9L treated with 1 (2 chloroethyl) 3 cyclohexyl 1 nitrosourea (CCNU). Vol.17. 1976
Effect of tetrahydrouridine (THU) on metabolism of cytosine arabinoside (ARA-C) in human leukemic cells. Vol.17. 1976
Combination therapy of malignant glioma with intravenous methyl CCNU (I.V. MeCCNU), epipodophyllotoxin (PTG) and radiotherapy. 16. 1975
Effects of daunomycin on human leukemic cells in vivo as studied by flow microfluorimetry. 16. 1975
Influence of poly A:U on immune responses in cancer patients. 16. 1975
Intensive drug combination and Ommaya device for prophylactic chemotherapy in lymphoblastic leukemia. 16. 1975
Metabolism of cytosine arabinoside (ARA C) in vitro by normal and leukemic blood and bone marrow. 16. 1975
Pharmacokinetics of five chemotherapeutic drugs in brain. 16. 1975
Trial of levamisole as immunopotentiator in cancer patients. Vol. 15. 1974

VIVO Weill Cornell Medical College

Proceedings of the American Association for Cancer Research Journal

Overview

publication venue for